NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
11/01/2021
Back to search
Official data from USPTO
SARAFEM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
11/01/2021
Trademark type
Word
Nice classes
5
Filing date
09/03/1998
Registration date
07/17/2001
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/01/2021
Last transaction
11/01/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
08/02/2000
First use in commerce
08/02/2000
Drawing code
1
Owner type
77
Owner location
COOLOCK, DUBLIN 17, IE
Examiner
DEFORD, JEFFREY S
Law office
M60
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED
WARNER CHILCOTT COMPANY, LLC
Warner Chilcott Company, Inc
Eli Lilly and Company
Representatives
Matthew O. Brady AbbVie
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system
Publications
History of USPTO decisions and trademark events.
43 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
11/01/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
11/01/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/01/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
06/17/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
07/17/2020
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
02/19/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/21/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/01/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/01/2014
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/23/2013
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
05/16/2012
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/18/2011
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/18/2011
FAXX
FAX RECEIVED
08/17/2011
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/01/2011
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
06/28/2011
89AF
REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
06/23/2011
E89R
TEAS SECTION 8 & 9 RECEIVED
06/23/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
04/06/2011
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/07/2009
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/30/2009
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/24/2009
CFIT
CASE FILE IN TICRS
03/01/2007
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/31/2007
PLGL
ASSIGNED TO PARALEGAL
01/31/2007
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
07/19/2006
E815
TEAS SECTION 8 & 15 RECEIVED
07/19/2006
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/13/2003
R.PR
REGISTERED-PRINCIPAL REGISTER
07/17/2001
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/12/2001
DOCK
ASSIGNED TO EXAMINER
01/16/2001
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/10/2001
EX2G
SOU EXTENSION 2 GRANTED
01/10/2001
IUAF
USE AMENDMENT FILED
11/02/2000
EXT2
SOU EXTENSION 2 FILED
11/02/2000
EX1G
SOU EXTENSION 1 GRANTED
06/27/2000
EXT1
SOU EXTENSION 1 FILED
04/28/2000
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
11/02/1999
PUBO
PUBLISHED FOR OPPOSITION
08/10/1999
NPUB
NOTICE OF PUBLICATION
07/11/1999
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/28/1999
DOCK
ASSIGNED TO EXAMINER
04/13/1999
Continuous trademark protection
Get notified about every new filing that threatens SARAFEM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.